ライフサイエンスコーパス: coenzyme Q10

1 is of glutathione, phospholipids, NADPH, and coenzyme Q10.

2 OQ2 and is essential for the biosynthesis of coenzyme Q10.

3 ebral cortex mitochondrial concentrations of coenzyme Q10.

4 wed that TQ is reduced more efficiently than coenzyme Q10.

5 eatine, 66 received minocycline, 71 received coenzyme Q10, 71 received GPI-1485, and 138 received pla

6 Treatment with coenzyme Q10, an essential cofactor of the electron tran

7 reased antioxidant defenses, a water-soluble coenzyme Q10 analog (Qter) was used.

8 cise duration remained unchanged in both the coenzyme Q10 and placebo groups.

9 outcome of a recent clinical trial examining coenzyme Q10 and remacemide in HD patients.

10 The combined treatment, using coenzyme Q10 and remacemide together, was more efficacio

11 ched control subjects and that the levels of coenzyme Q10 and the activities of complex I and complex

12 administration of the mitochondrial cofactor coenzyme Q10 and the NMDA antagonist remacemide.

13 c acid) or oil-soluble (vitamin E acetate or Coenzyme Q10) antioxidants.

14 Hereditary defects of coenzyme Q10 biosynthesis cause steroid-resistant nephro

15 we have identified 6 different mutations in coenzyme Q10 biosynthesis monooxygenase 6 (COQ6) in 13 i

16 mutations in genes that function within the coenzyme Q10 biosynthesis pathway, suggesting that SRNS

17 omparison of the rate of reduction of TQ and coenzyme Q10 by NQO1 showed that TQ is reduced more effi

18 They provide further evidence that coenzyme Q10 can exert neuroprotective effects that migh

19 econd step of the final reaction sequence of Coenzyme Q10 (CoQ) biosynthesis.

20 We focused on the coenzyme Q10 (CoQ10) biosynthesis gene Coq2, the silenci

21 DCK3, which has been shown to participate in coenzyme Q10 (CoQ10) biosynthesis.

22 investigated whether oral administration of coenzyme Q10 (CoQ10) could attenuate 1-methyl-4-phenyl-1

23 Primary coenzyme Q10 (CoQ10) deficiencies are rare, clinically h

24 The authors performed sequencing of known Coenzyme Q10 (CoQ10) deficiency genes in 22 patients wit

25 irst described in 1989, our understanding of coenzyme Q10 (CoQ10) deficiency is only now coming of ag

26 The use of coenzyme Q10 (CoQ10) has been increasing rapidly during

27 Coenzyme Q10 (CoQ10) has shown a protective effect in ne

28 Coenzyme Q10 (CoQ10) may represent a safe therapeutic op

29 Here we report the important role of the coenzyme Q10 (CoQ10) on the activity of caspase-2 upstre

30 ence available for oral supplementation with coenzyme Q10 (CoQ10) to improve the tolerability of canc

31 Coenzyme Q10 (CoQ10) was encapsulated successfully in a

32 evented the adverse effects of alcohol while coenzyme Q10 (CoQ10) was not very effective against alco

33 stnatal supplementation with the antioxidant coenzyme Q10 (CoQ10) would prevent this programmed pheno

34 Coenzyme Q10 (CoQ10), an antioxidant and mitochondrial c

35 Coenzyme Q10 (CoQ10), an antioxidant that supports mitoc

36 he effect of long-term (6 mo) treatment with coenzyme Q10 (CoQ10), an endogenous antioxidant.

37 olet, has been used for the determination of coenzyme Q10 (CoQ10).

38 fied starch (OSA-ST) was used to encapsulate coenzyme Q10 (CoQ10).

39 termediate in the synthesis of ubiquinone or coenzyme Q10 (CoQ10).

40 pe B inhibitors (selegiline and rasagiline), coenzyme Q10, creatine, and exercise in early Parkinson'

41 are due to defects in nuclear DNA, including coenzyme Q10 deficiency and mutations in genes controlli

42 Coenzyme Q10 deficiency appears to be a relatively commo

43 eficiency, and one patient was found to have coenzyme Q10 deficiency due to compound heterozygous mut

44 are due to defects in nuclear DNA, including coenzyme Q10 deficiency, and mutations in genes that con

45 Coenzyme Q10 does not affect ejection fraction, peak oxy

46 Levels of coenzyme Q10 in lymphoblastoid cells and brain tissue we

47 and antioxidant levels (alpha-tocopherol and coenzyme Q10) in brain PM during aging.

48 Feeding with coenzyme Q10 increased cerebral cortex concentrations in

49 ough the mean (+/-SD) serum concentration of coenzyme Q10 increased from 0.95+/-0.62 microg/mL to 2.2

50 ese results show that oral administration of coenzyme Q10 increases both brain and brain mitochondria

51 Coenzyme Q10 is an essential cofactor of the electron tr

52 Coenzyme Q10 is commonly used to treat congestive heart

53 vidence for managing myopathic patients with coenzyme Q10 is not conclusive.

54 Coenzyme Q10 is the electron acceptor for complex I and

55 cronutrients involved in cardiac metabolism: coenzyme Q10, l-carnitine, thiamine, and amino acids, in

56 Patients with ADCK4 mutations had lower coenzyme Q10 levels, and coenzyme Q10 supplementation am

57 Oral administration of coenzyme Q10 markedly attenuated striatal lesions produc

58 We found that oral administration of either coenzyme Q10 or remacemide significantly extended surviv

59 ductase 1, NADH-ferrocyanide reductase, NADH-coenzyme Q10 reductase, and NADH-cytochrome c reductase)

60 These data suggest that coenzyme Q10-related forms of SRNS and hearing loss can

61 In 12-month-old rats administration of coenzyme Q10 resulted in significant increases in cerebr

62 mutations had lower coenzyme Q10 levels, and coenzyme Q10 supplementation ameliorated renal disease i

63 Therapeutic trials of exercise training and coenzyme Q10 supplementation should continue to be offer

64 lls lacking MFN2 can be partially rescued by coenzyme Q10 supplementation, which suggests a possible

65 Some bioactive substances like coenzyme Q10, taurine, glutamine, creatine, creatinine,

66 enzoquinone (coenzyme Q1) as a surrogate for coenzyme Q10, the cofactor of this enzyme.

67 sed apoptosis that was partially reversed by coenzyme Q10 treatment.

68 ects of an antioxidant mixture of vitamin A, coenzyme Q10, vitamin C, and vitamin E were evaluated fo

69 A was more effective than ascorbic acid, and Coenzyme Q10 was more effective than vitamin E acetate.

70 Coenzyme Q10 was safe and well tolerated in this populat

71 We found that the level of coenzyme Q10 was significantly lower in mitochondria fro

72 decanoic acid) and lipophilic nutraceutical (Coenzyme Q10) was investigated using a rat feeding study